Since the SARS-CoV-2 outbreak in 2019, a diversity of viral genomic variants has emerged and spread globally due to increased transmissibility, pathogenicity, and immune evasion. By the first trimeste
*T universal epitope?Responses 14 days after the second dose of ICC 1132 (Day 70)?Responses 28 days after the third dose of ICC 1132 (Day 196)Differences between cohorts not statistically significant
